Literature DB >> 9621973

Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.

A Simmons1, M Smail, E Moore, S C Williams.   

Abstract

The precision of cerebral proton magnetic resonance spectroscopy (MRS) measurements is critical both in the clinical setting and for research purposes. Marshall et al. have recently concluded that "disappointing in vivo repeatability...is likely to limit" the ability of MRS to detect modest changes. We present here a comprehensive study of the precision of short- and long-term metabolite peak area ratios and water referenced metabolite peak areas for long echo time point resolved spectroscopy (PRESS) spectra (repetition time (TR) = 2000 ms, echo time (TE) = 136 ms) acquired from the occipital lobes of normal volunteers and a phantom using a conventional whole body 1.5 T MR system and conventional acquisition and analysis protocols. Short-term in vitro precision determined by five repeat scans on five occasions was excellent as measured by a mean coefficient of variation (NAA/Cho = 1.3%, NAA/Cr + PCr = 1.0%, Cho/Cr + PCr = 1.6%, NAA/H2O = 0.5%, Cho/H2O = 1.2%, Cr + PCr/H2O = 0.8%). Long term in vitro precision using 100 spectra acquired over 2 years was also very good (NAA/Cho = 2.7%, NAA/Cr + PCr = 1.4%, Cho/Cr + PCr = 2.2%, NAA/H2O = 1.5%, Cho/H2O = 2.4%, Cr + PCr/H2O = 1.5%). Short-term in vivo precision determined by five repeat scans in a single scanning session on eight subjects was also excellent (NAA/Cho = 5.2%, NAA/Cr + PCr = 3.0%, Cho/Cr + PCr = 6.6%, NAA/H2O = 1.4%, Cho/H2O = 4.9%, Cr + PCr/H2O = 2.7%) and only worsened slightly for long-term in vivo precision determined by five repeat scans on eight subjects over 3 months (NAA/Cho = 5.2%, NAA/Cr + PCr = 4.8%, Cho/Cr + PCr = 7.7%, NAA/H2O = 2.5%, Cho/H2O = 6.4%, Cr + PCr/H2O = 3.8%). We attribute the excellent precision reported here to the use of highly automated techniques for voxel shimming, water suppression and peak area measurements. These results allow us to repudiate Marshall's assertion regarding disappointing repeatability of in vivo MRS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621973     DOI: 10.1016/s0730-725x(97)00280-4

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  16 in total

1.  Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Authors:  Ivan I Kirov; Songtao Liu; Roman Fleysher; Lazar Fleysher; James S Babb; Joseph Herbert; Oded Gonen
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

2.  Limits of a localized magnetic resonance spectroscopy assay for ex vivo myocardial triacylglycerol.

Authors:  Robert D O'Connor; Robert J Gropler; Linda Peterson; Jean Schaffer; Joseph J H Ackerman
Journal:  J Pharm Biomed Anal       Date:  2007-09-01       Impact factor: 3.935

Review 3.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.

Authors:  J S Axford; F A Howe; C Heron; J R Griffiths
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

5.  Magnetic resonance markers of ischaemia: their correlation with vasodilatory reserve in patients with carotid artery stenosis and occlusion.

Authors:  D Lythgoe; A Simmons; A Pereira; M Cullinane; S Williams; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

6.  Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

Authors:  I Mader; W Roser; L Kappos; G Hagberg; J Seelig; E W Radue; W Steinbrich
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

7.  Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T.

Authors:  Ivan I Kirov; Lazar Fleysher; Roman Fleysher; Vishal Patil; Songtao Liu; Oded Gonen
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

8.  Reproducibility of serial whole-brain MR spectroscopic imaging.

Authors:  A A Maudsley; C Domenig; S Sheriff
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

9.  High dynamic-range magnetic resonance spectroscopy (MRS) time-domain signal analysis.

Authors:  William C Hutton; G Larry Bretthorst; Joel R Garbow; Joseph J H Ackerman
Journal:  Magn Reson Med       Date:  2009-10       Impact factor: 4.668

10.  ¹H-MR spectroscopy of adult-onset autosomal dominant leukodystrophy with autonomic symptoms.

Authors:  J Finnsson; A Melberg; R Raininko
Journal:  Neuroradiology       Date:  2013-05-01       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.